Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Adolescent Patients With Schizophrenia (ANCHOR 112)

This study has been completed.
Information provided by:
AstraZeneca Identifier:
First received: August 25, 2004
Last updated: January 3, 2013
Last verified: January 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2007
  Estimated Primary Completion Date: No date given